Stockreport

Oppenheimer Remains a Buy on CytomX Therapeutics (CTMX), Sets a $7 PT [Yahoo! Finance]

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF analyst Matthew Biegler maintained a Buy rating on CytomX Therapeutics, Inc. (NASDAQ:CTMX) and set a $7 price target. However, J.P. Morgan analyst Anupam Rama reiterat [Read more]